ALUMBRIA Trademark

Trademark Overview

On Friday, June 9, 2017, a trademark application was filed for ALUMBRIA with the United States Patent and Trademark Office. The USPTO has given the ALUMBRIA trademark a serial number of 87482500. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 25, 2021. This trademark is owned by Neos Therapeutics, Inc.. The ALUMBRIA trademark is filed in the Pharmaceutical Products category with the following description:

Prescription pharmaceutical preparations for the treatment of disease and disorders of the central nervous system
alumbria

General Information

Serial Number87482500
Word MarkALUMBRIA
Filing DateFriday, June 9, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 25, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements

Goods and ServicesPrescription pharmaceutical preparations for the treatment of disease and disorders of the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 16, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeos Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Prairie, TX 75050
Party NameNeos Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Prairie, TX 75050

Trademark Events

Event DateEvent Description
Monday, January 25, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 25, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, June 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 11, 2020EXTENSION 5 GRANTED
Friday, May 29, 2020EXTENSION 5 FILED
Thursday, June 11, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 29, 2020TEAS EXTENSION RECEIVED
Tuesday, September 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2019EXTENSION 4 GRANTED
Friday, September 20, 2019EXTENSION 4 FILED
Friday, September 20, 2019TEAS EXTENSION RECEIVED
Wednesday, June 12, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2019EXTENSION 3 GRANTED
Wednesday, June 12, 2019EXTENSION 3 FILED
Wednesday, June 12, 2019TEAS EXTENSION RECEIVED
Thursday, December 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 4, 2018EXTENSION 2 GRANTED
Tuesday, December 4, 2018EXTENSION 2 FILED
Tuesday, December 4, 2018TEAS EXTENSION RECEIVED
Monday, August 13, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 13, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 25, 2018EXTENSION 1 GRANTED
Friday, May 25, 2018EXTENSION 1 FILED
Friday, May 25, 2018TEAS EXTENSION RECEIVED
Tuesday, December 19, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 11, 2017ASSIGNED TO EXAMINER
Friday, June 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 13, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

alumbria central nervous system disorders disease pharmaceutical preparations treatment prescription